Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2017-03-15

Clinical Trial Update: Use of Santyl Within an Accountable Care Organization [Phase 4]

View source ↗

Summary

The Phase 4 trial evaluating Santyl (collagenase) for wound debridement in pressure ulcers and diabetic foot ulcers within an Accountable Care Organization has …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Santyl (collagenase)

Snippet

Sponsor: Smith & Nephew, Inc. | Conditions: Pressure Ulcer, Foot Ulcer, Diabetic | Phase 4 | Status: WITHDRAWN